Biovica

New data from the Personalised Disease Monitoring in Metastatic Breast Cancer study! 🎉 At #SABCS24! Come and listen to Dr. Sascha Howell present the latest findings with our biomarker DiviTum TKa. Poster session P5-02-16. Grab the chance to pose questions on Dec 13th, at 12:30-2 PM CT! See our SIX other poster presentations: https://loom.ly/I3O7VNA #biomarker #breastcancer #personalizedmedicine #divitum

New data from the MAINTAIN trial! 🎉 At #SABCS24! Come and listen to the latest findings with our biomarker DiviTum TKa. Poster session P4-01-22. Grab the chance to pose questions on Dec 12th, at 5:30-7 PM CT! See our SIX other poster presentations: https://loom.ly/I3O7VNA #biomarker #breastcancer #personalizedmedicine #divitum

New data from IRBLeida in Spain! 🎉 At #SABCS24! Come and listen to Dr. Serafin Morales present the latest findings with our biomarker DiviTum TKa. Poster session P4-01-25. Grab the chance to pose questions on Dec 12th, at 5:30-7 PM CT! See our SIX other poster presentations: https://loom.ly/I3O7VNA #biomarker #breastcancer #personalizedmedicine #divitum

New data from the TIRESIAS trial! 🎉 At #SABCS24! Come and listen to Dr. Luica Malorni from the Prato institute, Italy present the latest findings with our biomarker DiviTum TKa. Poster session P4-05-29. Grab the chance to pose questions on Dec 12th, at 5:30-7 PM CT! See our SIX other poster presentations: https://loom.ly/I3O7VNA #biomarker #breastcancer #personalizedmedicine #divitum

The Biovica Q2 report is out! Join our Earnings call later today: December 12th, 2024 at 15:00 CET. Click here to register: https://loom.ly/jqNehj0 Presenters are: Anders Rylander, CEO Anders Morén, CFO Hector Tamburini, Head of US Operations Henrik Winther, SVP Business Development #biovicb #investors #oncology #biomarker #pharma #Biovica

New data from the PACE Trial and the Dana Faber Cancer Institute! 🎉 At #SABCS24! Come and listen to Dr. Guilherme Nader-Marta present the latest findings with our biomarker DiviTum TKa. Poster session P2-07-25. Grab the chance to pose questions on Dec 11th, at 5:30-7 PM CT! See our SIX other poster presentations: https://loom.ly/I3O7VNA #biomarker #breastcancer #personalizedmedicine #divitum

New data from the Roswell Park! 🎉 At #SABCS24! Come and listen to Dr. Agnieszka K. Witkiewicz present the latest findings with our biomarker DiviTum TKa. Poster session P2-05-16. Grab the chance to pose questions on Dec 11th, at 5:30-7 PM CT! See our SIX other poster presentations: https://loom.ly/I3O7VNA #biomarker #breastcancer #personalizedmedicine #divitum

New data from the Penelope-B trial! 🎉 At #SABCS24! Come and listen to our Head of Clinical Development and Medical Affairs, Amy Williams, present the latest findings with our biomarker DiviTum TKa in Penelope-B. Poster Session: P1-09-06. Join us Wednesday, Dec 11th at 12:30-2 PM CT! Poster session P1-09-06. See our SIX other poster presentations: https://loom.ly/I3O7VNA #biomarker #pharma #personalizedmedicine #divitum #breastcancer

We are proud that there are no less than seven poster presentations with DiviTum TKa at this year's #SABCS24! The meeting is the world's largest meeting for healthcare professionals in breast cancer, and with SEVEN abstracts, we have between 1 and 3 daily presentations during 3 days of the symposium. See this and other events we attend here: https://loom.ly/I3O7VNA #biomarker #oncology #breastcancer #divitum #personalizedmedicine #pharma

Reminder: Join our Q2 Earnings Call. Thursday December 12th, 2024 at 15:00 CET! Register to participate: https://loom.ly/jqNehj0 Presenters are: Anders Rylander, CEO Hector Tamburini, Head of US Operations Henrik Winther, SVP Business Development Anders Morén, CFO #biovicb #investors #oncology #biomarker #pharma